look news india
Some scientists of Banaras Hindu University have conducted a new study. This research has been published in Science Journal. Scientists have conducted this study between January 2022 and August 2023. A total of 1,024 people were involved in this. Which included 635 teenagers and 291 adults. One year after the vaccine, these people were talked to over the phone.
What did the study find?
The study found that about a third of people who took Covaxin supplements developed serious side effects. Another important thing was that about 50 percent people complained of infection. Most of the cases were of respiratory infection. Of the 635 teenagers in the study, 10.5 percent developed skin disorders. nervous system disorders
Of the 635 adolescents included in the study, 10.5 percent had skin disorders. Neurological disorders were seen in 4.7% of adolescents and general disorders were seen in 10.2% of adolescents. Now, the same problems were found in teenagers among the 291 adults who were part of the study.
The percentage of common disorders among adults was 8.9%. Muscle and bone disorders were seen in 5.8% of people and nervous system disorders were seen in 5.5% of adults. Covaxin has serious side effects on women. Menstrual abnormalities were observed in 4.6% of women participating in the study. Eye problems were seen in 2.7% women and hypothyroidism in 0.6% women. Stroke in 0.3% and Guillain-Barré syndrome in 0.1% of participants. The short form GBS was also identified. GBS is a rare disease that gradually causes paralysis of large parts of the body.
How many deaths have occurred due to Covaxin?
Of the people who participated in the study, researchers found that four adults also died. This includes three women and one man. All four had diabetes, with three of the adults also having high blood pressure. Two of the four deaths were due to stroke.
One death was due to post-Covid gonadocerebral mucormycosis. Rhinocerebral mucormycosis is also known as zygomycosis. It is a rare and fatal disease that mainly affects the nose, paranasal sinuses, and brain. The fourth death was of a woman who fainted several times after vaccination. However, the reason for his fainting is not known. The study reported that adults who took three doses of Covaxin had four times the risk of AESI compared to adults who took two doses.
What clarification did the biotech company give?
After the research came to light, Bharat Biotech said that it has seen good safety results in several studies of the Covid-19 vaccine Covaxin. It has also been published in many major magazines. The company said in its statement that due to the security implications of this type of study, some data is needed to complete the information to avoid any bias. The company said that research shows this. Nor, what was the AESL profile of the people before participating in the study? This type of data was not included in BAU's research.
How much research should one be afraid of?
According to an infectious disease expert, of those who have been vaccinated in India, 90 per cent have taken Covishield and about 9.5 per cent have taken Covaxin and the rest have taken another company's vaccine. He says that the best thing about this study is that it is done at BHU. But its biggest drawback is that it has not compared the population. If 1000 people were studied in this research, then 1000 people who had taken the vaccine should have been included. Who were not vaccinated. The study should compare the safety profile of unvaccinated subjects with the safety profile of those who have received a second vaccine.
Finally, according to Tabi, an infectious disease expert, the research is believed to have been published in the journal Science. Which is a German British company. The AstraZeneca Covishield vaccine was manufactured by a German company. When the Covishield scam came to light, it was published in a fast-paced effort to convey to the public that Covaxin is not safe.
What is the last controversy of Covishield?
British pharmaceutical company AstraZeneca has admitted in court that its Covid-19 vaccine can cause serious side effects. The vaccine was also withdrawn a few days ago. We know this vaccine as Covishield in India. AstraZeneca developed the vaccine in collaboration with Oxford University and sent it to India in partnership with the Serum Institute. Death after vaccination. AstraZeneca is facing legal action over blood clots and other problems. Many families alleged that the vaccine had serious side effects.